Search Results

There are 4491 results for: content related to: New lipid-lowering drugs: an update

  1. You have free access to this content
    Recent developments in prostate cancer biomarker research: therapeutic implications

    British Journal of Clinical Pharmacology

    Volume 71, Issue 2, February 2011, Pages: 157–174, Sujitra Detchokul and Albert G. Frauman

    Article first published online : 28 JUL 2010, DOI: 10.1111/j.1365-2125.2010.03766.x

  2. Acupuncture for (sub)acute non-specific low-back pain

    Intervention Protocol

    The Cochrane Library

    Andrea D Furlan, Fatemeh Yazdi, Alexander Tsertsvadze, Lixing Lao, Karen Sherman, Carlo Ammendolia, Ellen Wang, Byung-Cheul Shin, Ikuro Wakayama and Maurits W van Tulder

    Published Online : 10 AUG 2011, DOI: 10.1002/14651858.CD009265

  3. You have free access to this content
    Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: New strategies for overcoming resistance to VEGFR and mTORC1 inhibitors

    International Journal of Cancer

    Volume 133, Issue 4, 15 August 2013, Pages: 788–796, Robert A. Figlin, Isabelle Kaufmann and Jillian Brechbiel

    Article first published online : 12 FEB 2013, DOI: 10.1002/ijc.28023

  4. Immune modulation for treatment of allergic disease

    Immunological Reviews

    Volume 242, Issue 1, July 2011, Pages: 258–271, Tran-Hoai T. Nguyen and Thomas B. Casale

    Article first published online : 20 JUN 2011, DOI: 10.1111/j.1600-065X.2011.01034.x

  5. You have full text access to this OnlineOpen article
    New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma


    Volume 118, Issue 6, 15 March 2012, Pages: 1486–1497, Mark Agulnik

    Article first published online : 11 AUG 2011, DOI: 10.1002/cncr.26361

  6. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date


    Jayson I. L. Bastien, Katharine A. McNeill and Howard A. Fine

    Article first published online : 23 SEP 2014, DOI: 10.1002/cncr.28968

  7. Role of targeted therapy in the treatment of advanced prostate cancer

    BJU International

    Volume 105, Issue 6, March 2010, Pages: 748–767, Karim Fizazi, Cora N. Sternberg, John M. Fitzpatrick, R. William Watson and Majid Tabesh

    Article first published online : 25 FEB 2010, DOI: 10.1111/j.1464-410X.2010.09236.x

  8. New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 975–1016, Estella M. Davis, Kathleen A. Packard, Jon T. Knezevich and Jennifer A. Campbell

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.10.975

  9. FMS Kinase Inhibitors: Current Status and Future Prospects

    Medicinal Research Reviews

    Volume 33, Issue 3, May 2013, Pages: 599–636, Mohammed I. El-Gamal, Hanan S. Anbar, Kyung Ho Yoo and Chang-Hyun Oh

    Article first published online : 20 MAR 2012, DOI: 10.1002/med.21258

  10. You have free access to this content
    Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 31–42, Phillip PARENTE, Francis PARNIS and Howard GURNEY

    Article first published online : 28 FEB 2012, DOI: 10.1111/j.1743-7563.2011.01506.x

  11. New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Article first published online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  12. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Article first published online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  13. You have free access to this content
    Recent advances in the pathophysiology and pharmacological treatment of obesity

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 525–535, P. K. Chugh and S. Sharma

    Article first published online : 29 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01347.x

  14. You have full text access to this OnlineOpen article
    Making progress: preserving beta cells in type 1 diabetes

    Annals of the New York Academy of Sciences

    Volume 1243, Issue 1, December 2011, Pages: 119–134, Mary Pat Gallagher, Robin S. Goland and Carla J. Greenbaum

    Article first published online : 23 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06321.x

  15. You have free access to this content
    Smoldering multiple myeloma: present position and potential promises

    European Journal of Haematology

    Volume 92, Issue 1, January 2014, Pages: 1–12, Nishant Tageja, Elisabet E. Manasanch, Neha Korde, Mary Kwok, Sham Mailankody, Manisha Bhutani, Mark Roschewski and Ola Landgren

    Article first published online : 26 NOV 2013, DOI: 10.1111/ejh.12205

  16. You have free access to this content
    MicroRNAome genome: A treasure for cancer diagnosis and therapy

    CA: A Cancer Journal for Clinicians

    Volume 64, Issue 5, September/October 2014, Pages: 311–336, Ioana Berindan-Neagoe, Paloma del C. Monroig, Barbara Pasculli and George A. Calin

    Article first published online : 7 AUG 2014, DOI: 10.3322/caac.21244

  17. When should FDG-PET be used in the modern management of lymphoma?

    British Journal of Haematology

    Volume 164, Issue 3, February 2014, Pages: 315–328, Sally Fiona Barrington and Nabegh George Mikhaeel

    Article first published online : 17 OCT 2013, DOI: 10.1111/bjh.12601

  18. Multiple Sclerosis Therapeutic Pipeline: Opportunities and Challenges

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 192–206, Stephen Krieger

    Article first published online : 21 MAR 2011, DOI: 10.1002/msj.20241

  19. Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

    Annals of the New York Academy of Sciences

    Volume 1263, Issue 1, August 2012, Pages: 43–56, Ira V. Gupta and Roxanne C. Jewell

    Article first published online : 25 JUL 2012, DOI: 10.1111/j.1749-6632.2012.06661.x

  20. Plant and Marine Sources

    Natural Products Analysis: Instrumentation, Methods, and Applications

    Amedeo Amedei, Elena Niccolai, Pages: 43–113, 2014

    Published Online : 19 SEP 2014, DOI: 10.1002/9781118876015.ch4